BDX Jan 2025 200.000 call
| Previous Close | 41.40 |
| Open | 49.11 |
| Bid | 47.30 |
| Ask | 52.30 |
| Strike | 200.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 49.11 - 49.11 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 26 |
GuruFocus.comBecton Dickinson & Co (BDX) Exceeds Q2 Earnings Estimates and Raises Fiscal 2024 Guidance
Strong Margin Execution and Cash Flow Highlight Second Quarter Performance
ZacksBecton Dickinson (BDX) Surpasses Q2 Earnings and Revenue Estimates
Becton Dickinson (BDX) delivered earnings and revenue surprises of 7.09% and 0.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Reuters
Becton Dickinson lifts profit view on strong surgical equipment demand
Becton Dickinson raised its annual profit forecast and beat second-quarter profit estimates on Thursday, as the group banks on strong demand for its surgical equipment and syringes. Medical technology firms like Becton, Boston Scientific and Abbott Laboratories are benefiting from a boost in demand as more people, especially older patients, undergo surgeries that were put on hold during the pandemic. The company's biggest unit, which makes devices to administer drugs, reported quarterly sales of $2.45 billion, in line with analysts' expectations, according to LSEG data.
